Research speed reading in 2021. Product Details of 2682-49-7, Catalysts allow a reaction to proceed via a pathway that has a lower activation energy than the uncatalyzed reaction. In a document type is Article, and a compound is mentioned, 2682-49-7, Thiazolidin-2-one, introducing its new discovery.
alpha-Glucosidase inhibitors have extensively been exploited for the effective management of type 2 diabetes and associated complications by significantly reducing the postprandial increase in glucose and plasma insulin levels. In this endeavour, we designed and synthesized a new series of coumarinyl iminothiazolidinone hybrid compounds (6a?o) using a one-pot multi-component approach. The hybrid structures were accessed in good chemical yields. The synthesized compounds were tested for their glucosidase inhibitory efficacy using acarbose as a standard inhibitor (IC50 = 38.2 ± 0.12 muM). In-vitro analysis of the hybrid molecules identified several potential leads for the development of potent glucosidase inhibitors with IC50 values in the range of 0.09?0.92 muM with compound 6g being the most potent drug candidate (IC50 = 0.09 ± 0.001 muM). Furthermore, compound 6f was identified as the lead inhibitor against maltase-glucoamylase with comparable inhibitory efficacy to acarbose with an IC50 value of 0.07 ± 0.016 muM. Binding interactions of potent compounds with the key residues in the active site of the glucosidase enzyme were revealed by molecular docking analysis. In summary, these new structural leads based on the hybrid pharmacophores could be developed as potential inhibitors of alpha-glucosidase for treating postprandial hyperglycemia.
Because enzymes can increase reaction rates by enormous factors and tend to be very specific, Product Details of 2682-49-7, typically producing only a single product in quantitative yield, they are the focus of active research.you can also check out more blogs about Product Details of 2682-49-7
Reference：
Quinuclidine – Wikipedia,
Quinuclidine | C7H319N | ChemSpider